• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of end-stage renal disease and dialysis modalities on blood ammonia level.终末期肾病及透析方式对血氨水平的影响。
Hemodial Int. 2017 Jul;21(3):343-347. doi: 10.1111/hdi.12510. Epub 2016 Nov 1.
2
Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis.血液透析期间呼出氨气与血尿素氮及肌酐的相关性
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4617-21. doi: 10.1073/pnas.071057598.
3
Exhaled breath volatile organic and inorganic compound composition in end-stage renal disease.终末期肾病患者呼出气体中挥发性有机化合物和无机化合物的成分
Clin Nephrol. 2016 Sep;86(9):132-40. doi: 10.5414/CN108614.
4
Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.不同透析液的血液透析患者透析期间血清镁的变化及其与低血压发作的关系。
Hemodial Int. 2006 Oct;10 Suppl 2:S16-23. doi: 10.1111/j.1542-4758.2006.00120.x.
5
Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.通过血液透析清除尿毒症潴留产物时,重要代谢产物也会被无差别地清除。
Clin Biochem. 2017 Dec;50(18):1078-1086. doi: 10.1016/j.clinbiochem.2017.09.012. Epub 2017 Sep 18.
6
Biochemical pathways of breath ammonia (NH3) generation in patients with end-stage renal disease undergoing hemodialysis.接受血液透析的终末期肾病患者呼出氨(NH₃)生成的生化途径。
J Breath Res. 2016 Aug 12;10(3):036011. doi: 10.1088/1752-7155/10/3/036011.
7
Excess morbidity in patients starting uremia therapy without prior care by a nephrologist.在未事先由肾病专家诊治的情况下开始接受尿毒症治疗的患者中存在额外的发病率。
Am J Kidney Dis. 1996 Dec;28(6):841-5. doi: 10.1016/s0272-6386(96)90383-2.
8
The breath ammonia measurement of the hemodialysis with a QCM-NH3 sensor.使用石英晶体微天平-氨传感器对血液透析过程中的呼出氨气进行测量。
Biomed Mater Eng. 2008;18(2):99-106.
9
Arteriovenous difference of blood ammonia in uremic patients under hemodialysis.血液透析患者尿毒症期血氨的动静脉差值
Artif Organs. 1998 Aug;22(8):703-5. doi: 10.1046/j.1525-1594.1998.06058.x.
10
Correlation between breath ammonia and blood urea nitrogen levels in chronic kidney disease and dialysis patients.慢性肾脏病和透析患者的呼吸氨与血尿素氮水平的相关性。
J Breath Res. 2020 Apr 28;14(3):036002. doi: 10.1088/1752-7163/ab728b.

引用本文的文献

1
Diverting the Diagnosis: A Case Report of Hemodialysis Masking the Etiology of Hyperammonemia.诊断转移:一例血液透析掩盖高氨血症病因的病例报告
Can J Kidney Health Dis. 2025 Jun 11;12:20543581251347154. doi: 10.1177/20543581251347154. eCollection 2025.
2
Host and fungal factors both contribute to cryptococcosis-associated hyperammonemia (cryptammonia).宿主和真菌因素均与隐球菌病相关的血氨过多症(cryptammonia)有关。
Microbiol Spectr. 2024 Jul 2;12(7):e0390223. doi: 10.1128/spectrum.03902-23. Epub 2024 Jun 6.
3
The Story of Ammonia in Liver Disease: An Unraveling Continuum.肝病中氨的故事:一个逐渐明晰的连续过程。
J Clin Exp Hepatol. 2024 Jul-Aug;14(4):101361. doi: 10.1016/j.jceh.2024.101361. Epub 2024 Feb 8.
4
Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease.肾脏病患者的酸中毒、认知功能障碍和运动功能障碍。
Nephrol Dial Transplant. 2021 Dec 28;37(Suppl 2):ii4-ii12. doi: 10.1093/ndt/gfab216.
5
Photoacoustic detection of ammonia exhaled by individuals with chronic kidney disease.个体呼出的氨的光声检测。
Lasers Med Sci. 2022 Mar;37(2):983-991. doi: 10.1007/s10103-021-03342-w. Epub 2021 May 28.
6
Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease.呼出的挥发性物质反映小儿慢性肾病的临床状况。
PLoS One. 2017 Jun 1;12(6):e0178745. doi: 10.1371/journal.pone.0178745. eCollection 2017.

本文引用的文献

1
The Gut as a Source of Inflammation in Chronic Kidney Disease.肠道作为慢性肾脏病炎症的一个来源。
Nephron. 2015;130(2):92-8. doi: 10.1159/000381990. Epub 2015 May 9.
2
Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.慢性肾脏病中肠道微生物菌群改变和肠上皮屏障结构与功能障碍:性质、机制、后果和潜在治疗。
Nephrol Dial Transplant. 2016 May;31(5):737-46. doi: 10.1093/ndt/gfv095. Epub 2015 Apr 16.
3
Urinary ammonia and long-term outcomes in chronic kidney disease.尿氨与慢性肾脏病的长期预后。
Kidney Int. 2015 Jul;88(1):137-45. doi: 10.1038/ki.2015.52. Epub 2015 Mar 11.
4
Gases as uremic toxins: is there something in the air?作为尿毒症毒素的气体:空气中有什么东西吗?
Semin Nephrol. 2014 Mar;34(2):135-50. doi: 10.1016/j.semnephrol.2014.02.006. Epub 2014 Feb 18.
5
Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.终末期肾病中含脲酶和尿酸酶、产生吲哚和对甲酚的肠道微生物群的扩张以及产生短链脂肪酸的肠道微生物群的收缩。
Am J Nephrol. 2014;39(3):230-237. doi: 10.1159/000360010. Epub 2014 Mar 8.
6
Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction.慢性肾脏病导致胃和小肠上皮紧密连接破坏。
Am J Nephrol. 2013;38(2):99-103. doi: 10.1159/000353764. Epub 2013 Jul 23.
7
Renal ammonia metabolism and transport.肾脏氨代谢与转运。
Compr Physiol. 2013 Jan;3(1):201-20. doi: 10.1002/cphy.c120010.
8
Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption.口服活性炭吸附剂(AST-120)可改善慢性肾脏病引起的肠道上皮屏障破坏。
Am J Nephrol. 2013;37(6):518-25. doi: 10.1159/000351171. Epub 2013 May 15.
9
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.针对转录因子 Nrf2 改善慢性肾脏病中的氧化应激和炎症。
Kidney Int. 2013 Jun;83(6):1029-41. doi: 10.1038/ki.2012.439. Epub 2013 Jan 16.
10
Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.尿素在慢性肾脏病中肠屏障功能障碍和上皮紧密连接破坏中的作用。
Am J Nephrol. 2013;37(1):1-6. doi: 10.1159/000345969. Epub 2012 Dec 19.

终末期肾病及透析方式对血氨水平的影响。

Effects of end-stage renal disease and dialysis modalities on blood ammonia level.

作者信息

Vaziri Nosratola D, Khazaeli Mahyar, Nunes Ane C F, Harley Kevin T, Said Hyder, Alipour Omeed, Lau Wei Ling, Pahl Madeleine V

机构信息

Division of Nephrology and Hypertension, University of California, Irvine, Irvine, California, USA.

出版信息

Hemodial Int. 2017 Jul;21(3):343-347. doi: 10.1111/hdi.12510. Epub 2016 Nov 1.

DOI:10.1111/hdi.12510
PMID:27804262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5812671/
Abstract

INTRODUCTION

Uremia results in a characteristic breath odor (uremic fetor) which is largely due to its high ammonia content. Earlier studies have shown a strong correlation between breath ammonia and blood urea levels and a 10-fold reduction in breath ammonia after hemodialysis in patients with chronic kidney disease. Potential sources of breath ammonia include: (i) local ammonia production from hydrolysis of urea in the oropharyngeal and respiratory tracts by bacterial flora, and (ii) release of circulating blood ammonia by the lungs. While the effects of uremia and hemodialysis on breath ammonia are well known their effects on blood ammonia are unknown and were explored here.

METHODS

Blood samples were obtained from 23 hemodialysis patients (immediately before and after dialysis), 14 peritoneal dialysis patients, and 10 healthy controls. Blood levels of ammonia, creatinine, urea, and electrolytes were measured.

FINDINGS

No significant difference was found in baseline blood ammonia between hemodialysis, peritoneal dialysis and control groups. Hemodialysis procedure led to a significant reduction in urea concentration (P < 0.001) which was paradoxically accompanied by a modest but significant (P < 0.05) rise in blood ammonia level in 10 of the 23 patients studied. Change in blood ammonia pre- and post-hemodialysis correlated with change in serum bicarbonate levels (r = 0.61, P < 0.01). On subgroup analysis of patients who had a rise in blood ammonia levels after dialysis, there was a strong correlation with drop in mean arterial pressure (r = 0.88, P < 0.01). The nadir intradialytic systolic blood pressure trended lower in the hemodialysis patients who had a rise in blood ammonia compared to the patients who manifested a fall in blood ammonia (124 ± 8 vs. 136 ± 6 mmHg respectively, P = 0.27).

DISCUSSION

Fall in blood urea following hemodialysis in ESRD patients was paradoxically accompanied by a modest rise in blood ammonia levels in 43% of the patients studied, contrasting prior reported effects of hemodialysis on breath ammonia. In this subgroup of patients, changes in blood ammonia during hemodialysis correlated with rise in blood bicarbonate and fall in mean arterial blood pressure.

摘要

引言

尿毒症会导致一种特征性的呼吸气味(尿毒症口臭),这主要归因于其高氨含量。早期研究表明,呼出气体中的氨与血尿素水平之间存在很强的相关性,并且慢性肾病患者在血液透析后呼出气体中的氨含量降低了10倍。呼出气体中氨的潜在来源包括:(i)口腔和呼吸道中的细菌菌群将尿素水解产生局部氨,以及(ii)肺释放循环血液中的氨。虽然尿毒症和血液透析对呼出气体中氨的影响是众所周知的,但它们对血氨的影响尚不清楚,本文对此进行了探讨。

方法

采集了23名血液透析患者(透析前和透析后即刻)、14名腹膜透析患者和10名健康对照者的血样。测量了血液中的氨、肌酐、尿素和电解质水平。

研究结果

血液透析组、腹膜透析组和对照组的基线血氨水平无显著差异。血液透析过程导致尿素浓度显著降低(P<0.001),但在23名研究患者中的10名患者中,反常地伴随着血氨水平适度但显著(P<0.05)升高。血液透析前后血氨的变化与血清碳酸氢盐水平的变化相关(r = 0.61,P<0.01)。在对透析后血氨水平升高的患者进行亚组分析时,发现与平均动脉压下降有很强的相关性(r = 0.88,P<0.01)。与血氨降低的患者相比,血氨升高的血液透析患者透析期间收缩压最低点的趋势更低(分别为124±8 vs. 136±6 mmHg,P = 0.27)。

讨论

在研究的患者中,43%的患者在血液透析后血尿素降低的同时,血氨水平适度升高,这与先前报道的血液透析对呼出气体中氨的影响形成对比。在这一亚组患者中,血液透析期间血氨的变化与血碳酸氢盐升高和平均动脉血压下降相关。